Prosecution Insights
Last updated: October 02, 2026

Examiner: SMALL, KATHERINE R

Tech Center 1600 • Art Units: 1633

This examiner grants 69% of resolved cases

Analysis

Katherine R. Small works in Art Unit 1633 within Tech Center 1600. The examiner has resolved 61 cases with an allowance rate of 68.9 percent. This provides a focused view of the examiner's performance in specialized arts. Practitioners should note the 68.9 percent allowance rate when preparing their applications for review.

The interview lift is 30.7 percent, showing that interviews are a strong tactic for increasing the probability of a grant. This 30.7 percent lift suggests that direct dialogue is particularly effective in Art Unit 1633 for overcoming technical rejections. Practitioners should consider these 61 resolved cases when deciding on their interview strategy.

However, the median days to allowance is 1418, indicating a relatively long prosecution period. This duration of 1418 days is a critical factor for applicants to consider in Tech Center 1600. The combination of a moderate allowance rate and a lengthy pendency suggests that while success is likely, it may require significant time and effort.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

68.9%
Allow Rate
+8.9% vs TC avg
79
Total Applications
+30.7%
Interview Lift
1418
Avg Prosecution Days
Based on 61 resolved cases, 2023–2026

Rejection Statute Breakdown

4.9%
§101 Eligibility
23.9%
§102 Novelty
41.4%
§103 Obviousness
27.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18692493 AAV PARTICLES WITH MODIFIED INVERTED TERMINAL REPEATS FOR ENHANCED GENE EXPRESSION IN MUSCLE Non-Final OA University of Florida Research Foundation, Incorporated
18339930 Compositions and Methods for Genetically Modifying CIITA in a Cell Non-Final OA Intellia Therapeutics, Inc.
17423246 FUNCTIONALIZED SUBSTRATE TO MANIPULATE CELL FUNCTION AND DIFFERENTIATION Final Rejection KONINKLIJKE PHILIPS N.V.
17638355 CRISPR-ASSOCIATED MU TRANSPOSASE SYSTEMS Non-Final OA MASSACHUSETTS INSTITUTE OF TECHNOLOGY
18625740 HUMAN CEREBELLAR ORGANOIDS WITH BONA FIDE PURKINJE CELLS AND USES THEREOF Non-Final OA University of Southern California

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month